About the Gout Working Group
Gout is the most common form of inflammatory arthritis and is caused by deposition of monosodium urate (MSU) crystals in and around joints, which provokes an intense inflammatory response. Gout manifests as episodes of intense joint pain, swelling, and functional disability that may lead to persistent joint symptoms and structural joint damage.
In our pursuit of ensuring that research aligns with the needs and interests of those most affected by gout, our team has diligently worked on the identification and consensus of the most crucial outcomes to be measured in all clinical trials and observational studies of gout.
Our work so far has incorporated key elements of the OMERACT Framework, including a thorough literature review, Delphi surveys, and patient involvement at all stages of the research process. We have developed a Core Domain Set that reflects not only the clinical aspects of gout but also the lived experience of patients.
Building on the progress we've made, our next focus is to provide explicit guidance on the measurement methods and reporting needs for the core outcome set.
Jasvinder A. Singh
Working Group Publications
ENDORSED DOMAINS FOR ACUTE GOUT
ENDORSED DOMAINS FOR CHRONIC GOUT
Working Group Members:
Aya Akmal Amin
Carlos Guillen Astete
Esther Francisca Vicente-Rabaneda
Hilde Berner Hammer
Ingrid Moller Parera
Jan Ren√© Nkeck
Karen Natali Saravia Chocobar
Khaled Abdelsalam Abdelgalil
Kyung Min Ko
Lays De Souza
Lizeth Chaparro Del Portillo
M Masudul Hassan
Madusha Menu Cristeen Jayasinghe
Win Min Oo